"AZ Nikolaas (fusie AZ Waasland en AZ Maria Middelares) telt 810 bedden. Het ziekenhuis heeft 5 campussen in het Waasland: Sint-Niklaas, Temse, Hamme, Beveren en Sint-Gillis-Waas. In Lokeren heeft het ziekenhuis een aparte low care afdeling. Dagelijks kunnen we rekenen op de inzet van meer dan 2300 medewerkers waarvan ruim 230 artsen. Zij bieden op deskundige wijze specialistische gezondheidszorg en dringende medische hulpverlening aan gehospitaliseerde en ambulante patiënten."

During the past decade, AZ Nikolaas conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 8 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 5 clinical trials were completed. i.e. 10.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AZ Nikolaas" #1 sponsor was "University Hospital, Antwerp" with 8 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Universitaire Ziekenhuizen KU Leuven" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AZ Nikolaas" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "Kom Op Tegen Kanker" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Universiteit Antwerpen" with 3 trials as a collaborator and "University Ghent" with 3 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "AZ Nikolaas" are "Depressive Disorder, Major" (3 trials), "Failed Back Surgery Syndrome" (3 trials), "Multiple Myeloma" (3 trials), "Breast Cancer" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "AZ Nikolaas" in a lesser frequency.

Most popular intervention types in "AZ Nikolaas" are "Drug" (46 trials), "Other" (12 trials), "Device" (8 trials), "Biological" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Pembrolizumab" (7 trials), "Carboplatin" (5 trials), "Atezolizumab" (3 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "AZ Nikolaas" are 72 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 52 active trials in "AZ Nikolaas". 2 are not yet recruiting, 36 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in AZ Nikolaas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in AZ Nikolaas, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 16 trials that are defined as “Not Applicable".